ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Dana-Farber Cancer Institute 

44 Binney Street

Boston  Massachusetts  02115  U.S.A.
Phone: 617-632-3000 Fax: n/a


SEARCH JOBS
The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Vision

Dana-Farber Cancer Institute's ultimate goal is the eradication of cancer, AIDS, and related diseases and the fear that they engender.

Core Values

Impact

Above all else, we make a difference by relieving the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.

Excellence
We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct.

Compassion and Respect
For those in our care and for one another.

Discovery
We foster the spirit of inquiry, promoting collaboration and innovation across traditional boundaries while celebrating individual creativity.

www.Dana-FarberCareers.com


 Key Statistics


Email: Dana-FarberContactUs@dfci.harvard.edu
Ownership: Private

Web Site: Dana-Farber Cancer Institute
Employees:
Symbol: 
 









 Company News
Dana-Farber Cancer Institute Scientists Find Mutation Driving Pediatric Brain Tumors 5/1/2013 7:32:09 AM    More...
BrainStorm Cell Therapeutics Inc. Partners With Dana-Farber Cancer Institute for NurOwn™ Production in Phase II ALS Clinical Trial 4/8/2013 9:29:34 AM    More...
Screening Blood Samples for Cancer-Driving Mutations More Comprehensive Than Analyzing Traditional Tumor Biopsy, Dana-Farber Cancer Institute and Harvard Medical School Study 4/8/2013 8:11:01 AM    More...
Some Incurable BRCA Patients Respond to New 2-Drug Combo, Dana-Farber Cancer Institute Study 4/8/2013 7:54:23 AM    More...
The Mikey Czech Foundation Contributes $500,000 to DIPG Research at Dana-Farber Cancer Institute - Harvard Medical School 4/2/2013 9:49:34 AM    More...
Molecular "Signature" for Rapidly Increasing Form of Esophageal Cancer Discovered, Dana-Farber Cancer Institute Study 3/25/2013 7:27:37 AM    More...
Rheumatoid Arthritis Prevented in Mice: Infusions of Regulatory T Cells Turn Off Autoimmune Attack on Joints, Dana-Farber Cancer Institute Study 2/11/2013 7:24:13 AM    More...
New Method Identifies Genes That Can Predict Prognoses of Cancer Patients, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and IRCM Study 1/28/2013 7:30:20 AM    More...
Mutations Found in "Junk" DNA May be Driving Skin Cancers, Dana-Farber Cancer Institute Study 1/25/2013 7:45:41 AM    More...
Some Men Complaint of Shortened Penis Following Prostate Cancer Treatment, Dana-Farber Cancer Institute and Brigham and Women's Hospital Study 1/3/2013 7:33:17 AM    More...
12345678910...